ProCE Banner Activity

How I Manage My Patients With MCL, CLL, and SLL

Clinical Thought

Expert nurse practitioner Beth Faiman discusses evidence-based recommendations for how best to incorporate new therapeutic options for patients with chronic lymphocytic leukemia and mantle cell lymphoma.

Released: June 16, 2022

Expiration: June 15, 2023

Share

Faculty

Beth Faiman

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center 9500 Euclid Avenue CA-6
Cleveland, Ohio

Acknowledgement

This activity is supported an educational grant from AstraZeneca.

Supporters

AstraZeneca

Target Audience

NPs and PAs in oncology

Disclosure

Beth Faiman PhD, MSN, APRN-BC, AOCN has no relevant financial relationships to disclose.

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Additional Information

Program Medium

This program has been made available online.